Beta Drugs NSE
630.00 00.00 (1.04%) 
To view real-time data of Beta Drugs and trade with industry first features, Login or Open Free Demat Account.
Company Fundamentals
Company Valuation
| Market Cap (Rs Cr.) | 586.44 |
| Book Value (Rs) | 80.57 |
| Face Value (Rs) | 10.00 |
| P/E ratio | 41.16 |
| Dividend Yield | 0.0 % |
Ownership & Shareholding
Company Ownership
Shareholding Pattern
Sector
| Sector | Pharmaceuticals |
| Sub Sector | - |
| Company Classification | Smallcap |
Exchange Scrips
| BSE | sec_id |
| NSE | sec_id |
| ISIN | INE351Y01019 |
Stock Part of Following Indices
| Name | Current Value | Change |
Beta Drugs Fundamental Analysis Overview
Beta Drugs Fundamental Analysis offers an overview of the company's Market Capitalization, Book Value, P/E Ratio, Dividend Yield and more. It helps to analyse the company's fundamental position and its current shareholding pattern and historical shareholding movement. Presently, the current market cap of Beta Drugs is Rs. 586.44. The Face Value and Book Value per share are Rs. 10.00 and Rs. 80.57 respectively. Current P/E ratio of Beta Drugs stands at 41.16. The promoters holding in the company stands at , while Domestic Institutions stand at 00.00% and Foreign Institutions hold 00.00. While understanding and analysing Fundamentals of a company is very crucial, it is equally important to look at the Share Price, Stock Performance, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
